Barclays »

Lexeo Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Lexeo Therapeutics (LXEO) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Lexeo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lexeo Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexeo Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2024-03-31 $359k 23k 15.66
2023-12-31 $208k 16k 13.40

More positions owned by Barclays

Invesco Qqq Tr Fund (QQQ)
Microsoft Corp Opt Put Option (MSFT)
Ishares Tr Fund (IWM)
Apple Opt Call Option (AAPL)
SPDR S&ampP 500 ETF TR Fund (SPY)
Nvidia Corporation Opt Call Option (NVDA)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Facebook Inc cl a (META)
Tesla Motors (TSLA)
Alphabet Opt Put Option (GOOG)
Visa Opt Put Option (V)
Broadcom Opt Call Option (AVGO)
Berkshire Hathaway (BRK.B)
JPMORGAN CHASE &amp Opt Put Option (JPM)

View all positions for Barclays

Top funds holding Lexeo Therapeutics

Eventide Asset Management
Henderson Group
Citadel Advisors
Omega Fund Management
Adage Capital Partners GP
Braidwell
Artal Group
Blackstone Group
BlackRock
RA Capital Management
Millennium Management
Vanguard Group
Laurion Capital Management
Geode Capital Management
Cornell University

View all funds holding Lexeo Therapeutics